Navigation Links
Immune Deficiency Foundation Praises ACHDNC Recommendation for SCID Screening in Newborns
Date:1/25/2010

WASHINGTON, Jan. 25 /PRNewswire/ -- On January 21, 2010, the Advisory Committee on Heritable Disorders in Newborns and Children voted unanimously to add screening for Severe Combined Immune Deficiency or SCID -- commonly known as bubble boy disease -- to the core panel for universal screening of all newborns in the United States.

SCID is a primary immunodeficiency; affected infants lack T lymphocytes, the white blood cells that help resist infections due to a wide array of viruses, bacteria and fungi. Babies with SCID appear healthy at birth, but without early treatment, most often by bone marrow transplant from a healthy donor, these infants cannot survive.

The Advisory Committee's policy recommendation will now be presented to Kathleen Sebelius, Secretary of Health and Human Services. Ms. Sebelius has 180 days to consider and respond to the committee's proposal.

Jennifer Puck, Professor of Pediatrics at the University of California, San Francisco and an expert in the field, nominated SCID for consideration by the Committee after pioneering development of a test that can detect SCID in the dried blood spot filter cards that are currently collected from all babies to screen for a variety of inborn disorders.

"The Advisory Committee has taken a momentous step forward for the primary immunodeficiency community," said Marcia Boyle, President & Founder of the Immune Deficiency Foundation (IDF), the national patient organization for persons with primary immunodeficiency diseases. "The IDF has strongly supported and worked tirelessly toward this goal for many years. But it is imperative that we sustain this momentum by working to establish newborn screening programs in all 50 states."

The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) was chartered in February 2003 to perform evidence-based reviews and advise the Secretary regarding application of new screening tests, technologies, policies, guidelines and standards for effectively reducing morbidity and mortality in newborns and children having, or at risk for, heritable disorders. SCID is the first new disease to be recommended for addition to the federal uniform core-screening panel by the evidence-based Committee review process.

"Although this recommendation has been in development for two years," said Dr. Amy Brower, parent, researcher and former ACHDNC committee member, "and it may take several more years to implement screening in all 50 states and US territories, we must work to reduce the time from this recommendation to the widespread adoption of testing and treatment."

In 2004, Duke University Professor of Pediatrics and Immunology, Dr. Rebecca H. Buckley -- currently the chair of the Immune Deficiency Foundation's Medical Advisory Committee and an internationally known expert on SCID --  testified before the ACHDNC (to which she was subsequently appointed in 2007).

Dr. Buckley informed the panel that SCID is a pediatric emergency. If a baby with SCID receives a bone marrow transplant in the first 3.5 months of life, the survival rate can be as high as 94 percent. However, the survival rate drops to less than 70 percent for infants who are transplanted after that age. The main causes for the drop in survival rate are serious infections babies with SCID develop prior to transplantation.

"As the parent of a child who was diagnosed with SCID only after he became critically ill," said Barb Ballard, a member of the IDF Board of Trustees, "I have to say I am immensely pleased with the recommendation of the committee."

In addition to the IDF, the Jeffrey Modell Foundation and members of the public whose children were affected with SCID argued in favor of SCID screening. One child born in Wisconsin, where pilot SCID screening is ongoing, was diagnosed at 9 days of age and successfully cured by timely bone marrow transplantation, while another child born in Oregon, where screening does not take place, developed failure to thrive and multiple infections and did not survive.

"Our goal is to have Newborn Screening for SCID passed in all 50 states," said Heather Smith, co-founder of SCID Angels for Life, who lost her six-month-old son, Brandon, to this devastating disease.

"We have already lost way too many children to this disease," Ms. Smith concluded, "and newborn screening is the only way we can put an end to the pain and suffering these children are forced to endure."

The Immune Deficiency Foundation is the national patient organization dedicated to improving the diagnosis, treatment and quality of life of persons with primary immunodeficiency diseases through advocacy, education and research. For information on this media release, please contact Marcia Boyle, president, at 410-321-6647 or idf@primaryimmune.org. For further information please visit the IDF website at www.primaryimmune.org, or call IDF at 800-296-4433.

SOURCE Immune Deficiency Foundation

RELATED LINKS
http://www.primaryimmune.org

'/>"/>

SOURCE Immune Deficiency Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Immune Response Better With Skin Scratch Vaccination
2. Cancer stem cells suppress immune response against brain tumor
3. MBM ScienceBridge GmbH Negotiates License Agreement Between the Georg-August-University Gottingen, Universitatsmedizin, the University of Regensburg, and the UKs Medical Research Council Technology for a New Therapy of Inflammatory and Immune Disea
4. NEI Guided Nutrition Program(TM) is Second Entrant in Medical Arsenal for Neuro-Endocrine-Immune Supersystem(C) Product and Testing Protocols
5. Immune responses to tetanus vaccine unchanged for RA patients on rituximab
6. Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com
7. Immune cell activity linked to worsening COPD
8. Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
9. DNA Test May Detect Immune Disorder in Infants
10. Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients
11. The Chopra Center for Wellbeing Launches Vedamune: An Ayurvedic Supplement to Support The Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Nike Yoga Camps at East ... practices, arts & crafts, discussions, and games all geared towards enhancing your child’s ... combined backgrounds in kids’ yoga, collegiate sport yoga instruction, and global yoga training. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Eugene Batelli, D.P.M., F.A.C.F.A.S, is ... wonderful accolades and stellar patient reviews, Dr. Batelli continues to be recognized for ... Batelli is a highly trained Podiatric Surgeon who specializes in treating athletes and ...
(Date:5/26/2016)... ... 2016 , ... OncLive® , a leading digital provider ... University of Virginia (UVA) Cancer Center to its quickly expanding Strategic ... will publicize and promote public awareness of UVA Cancer Center’s latest advances in ...
(Date:5/26/2016)... Pittsburgh, PA (PRWEB) , ... May 26, 2016 , ... ... THE PROS WHILE ADDING PROTECTION TO YOUR HEAD ™”. , “We are ... Soccer Team. On the football front we have Brian Quick, wide receiver for Los ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... enhance surgical safety efforts for several years, and the efforts have paid off. ... These efforts include new standards of care to enhance perioperative patient experiences and ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 Cirujanos ... para ayudar a los médicos a compartir sus mejores ... a escala mundial. Profesionales médicos de Europa, África, ... han apuntado a la aplicación, que combina la transmisión ... entorno totalmente seguro. Educación   "Imagine ...
(Date:5/24/2016)... 24, 2016 ARANZ Medical  Ltd ... healthcare sector, has been named the Coretex Hi-Tech Emerging Company ... Dr Bruce Davey , CEO of ARANZ ...  It,s really good to be recognised for the work we ... are used in 35 countries around the world from Sub-Saharan ...
(Date:5/24/2016)... KONG , May 24, 2016 ... , the world , s first ... AV fistula intervention   OrbusNeich, a global ... has expanded its portfolio to include products to treat ... are the company,s first entry devices for lower limb ...
Breaking Medicine Technology: